Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
Condition: Breast CancerInterventions: Drug: Tamoxifen Citrate; Drug: Placebo; Procedure: Digital mammography; Other: immunohistochemistry staining method; Other: pharmacological study; Other: laboratory biomarker analysis; Genetic: protein expression analysis; Other: pharmacogenomic studies; Other: questionnaire administration; Procedure: Fine needle aspiration; Other: Quality of Life AssessmentSponsors: City of Hope Medical Center; National Cancer Institute (NCI); St. Jude Children's Research Hospital; University Health Network, Toronto; University of Michigan; Dana-Farber Cancer Institute; Mayo Clinic; University of WashingtonRecruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Needle Aspiration | Cancer | Cancer & Oncology | Children | Genetics | Hospitals | Mammography | Research | Study | Tamoxifen